Ruxolitinib in combination with prednisone and nilotinib exhibit synergistic effects in human cells lines and primary cells from myeloproliferative neoplasms

por Cortés, Alicia Arenas, Diaz, Rosa Ayala, Hernández-Campo, Pilar, Gorrochategui, Julián, Primo, Daniel, Robles, Alicia, Morales, María Luz, Ballesteros, Joan, Rapado, Inmaculada, Gallardo, Miguel, Linares, María, Martínez-López, Joaquín
Publicado 2019